ARK THERAPEUTICS LTD has a total of 228 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United Kingdom, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are MULTHOFF GABRIELE, LYMPHOTEC INC and ITESCU SILVIU.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 39 | |
#2 | EPO (European Patent Office) | 31 | |
#3 | WIPO (World Intellectual Property Organization) | 27 | |
#4 | Australia | 23 | |
#5 | Canada | 21 | |
#6 | China | 15 | |
#7 | Mexico | 10 | |
#8 | Norway | 10 | |
#9 | United States | 10 | |
#10 | Poland | 8 | |
#11 | South Africa | 8 | |
#12 | Hungary | 6 | |
#13 | Israel | 6 | |
#14 | Republic of Korea | 6 | |
#15 | Japan | 3 | |
#16 | Brazil | 2 | |
#17 | African Regional Industrial Property Organization | 1 | |
#18 | Hong Kong | 1 | |
#19 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Medical technology | |
#5 | Foods and drinks | |
#6 | Agriculture | |
#7 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Implantable devices | |
#6 | Enzymes | |
#7 | Heterocyclic compounds | |
#8 | Animal care | |
#9 | Combinatorial chemistry | |
#10 | Special macromolecular compounds |
# | Name | Total Patents |
---|---|---|
#1 | Yla-Herttuala Seppo | 67 |
#2 | Airenne Kari Juhani | 34 |
#3 | Martin John Francis | 31 |
#4 | Selwood David | 25 |
#5 | Zachary Ian | 24 |
#6 | Jia Haiyan | 19 |
#7 | Montgomery Hugh Edward | 17 |
#8 | Laitinen Olli | 13 |
#9 | Barker Stephen George Edward | 13 |
#10 | Schenkwein Diana | 12 |
Publication | Filing date | Title |
---|---|---|
GB201116880D0 | Vector | |
GB201111218D0 | Sequence | |
GB201111219D0 | Sequence | |
GB201100804D0 | Drug combination | |
GB0921430D0 | Protein for therapeutic use | |
GB0916997D0 | Combination therapy | |
GB0914856D0 | Compounds | |
GB0914855D0 | Nucleotide | |
GB0910950D0 | Filtration | |
GB0818663D0 | Gene regulation and its use in therapy | |
GB0803395D0 | Medicament | |
GB0715722D0 | Filtration | |
GB0715725D0 | Assay | |
GB0715724D0 | Enzyme analysis | |
GB0715723D0 | Formulation | |
GB0711856D0 | Medical device | |
GB0710535D0 | Baculovirus generation | |
GB0710457D0 | Vegf Mutants | |
GB0703683D0 | The treatment of complications in pregnancy | |
GB0702695D0 | Production of vectors |